Ono Pharmaceutical Co., Ltd. (OPHLY) Financials

OPHLY Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 7.0 billion 1.6 billion
Dec. 31, 2025 6.9 billion 1.5 billion
Sept. 30, 2025 7.3 billion 1.7 billion
June 30, 2025 7.1 billion 1.7 billion

OPHLY Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 311.7 million ?
Dec. 31, 2025 204.4 million ?
Sept. 30, 2025 346.0 million ?
June 30, 2025 7.8 million ?

OPHLY Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 5.2 million
Dec. 31, 2025 187.6 million
Sept. 30, 2025 154.7 million
June 30, 2025 122.9 million

OPHLY Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 1.5 billion 471.6 million 47.0 million
Dec. 31, 2025 1.2 billion 575.4 million 48.4 million
Sept. 30, 2025 1.3 billion 617.8 million 52.1 million
June 30, 2025 967.6 million 678.0 million 73.8 million

OPHLY Shares Outstanding

No data available :(

OPHLY Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 6.3 million 270.9 million 196.3 million -
Dec. 31, 2025 6.6 million 217.9 million 206.2 million -
Sept. 30, 2025 11.5 million 239.0 million 206.8 million -
June 30, 2025 15.6 million 252.1 million 216.2 million -

OPHLY Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 757.1 million 210.8 million
Dec. 31, 2025 909.1 million 238.4 million
Sept. 30, 2025 890.9 million 240.4 million
June 30, 2025 886.8 million 257.4 million

OPHLY

Price: $4.87

52 week price:
3.41
5.75

Dividend Yield: 2.70%

Earnings Per Share: 0.31 USD

P/E Ratio: 16.16

Exchange: PNK

Sector: Healthcare

Industry: Drug Manufacturers - General

Market Capitalization: 7.0 billion

Links: